Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext - PDF (Russian)


Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies